Search
for
Sort by
Research 31–60 of 1000+
- Targets to treat androgen excess in polycystic ovary syndrome
- Hair: What is New in Diagnosis and Management?
- Male androgenetic alopecia (Part II)
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- O que sabemos sobre os inibidores da 5 alfa redutase?
- Adverse effects of common medications on male fertility
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- 5α-Reduced glucocorticoids: a story of natural selection
- Update on Frontal Fibrosing Alopecia
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Female Pattern Hair Loss
- Androgenetic alopecia; drug safety and therapeutic strategies
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Clinical biochemistry of dihydrotestosterone
- Revisión actualizada del tratamiento de la alopecia androgenética femenina
- Inibição seletiva da 5α-redutase e preservação da aromatase no transplante capilar
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University
- Hormonal Therapy for Acne
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Androgen Receptor (<i>AR</i>) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- A high-performance liquid chromatography–tandem mass spectrometry assay of the androgenic neurosteroid 3α-androstanediol (5α-androstane-3α,17β-diol) in plasma
- Managing patterned hair loss – a hair raising task!
- Biphasic Regulation of HMG-CoA Reductase Expression and Activity during Wound Healing and Its Functional Role in the Control of Keratinocyte Angiogenic and Proliferative Responses
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Association of Suicidality and Depression With 5α-Reductase Inhibitors